Connect your AI

BioCryst Pharmaceuticals BCRX Price / sales

Price / sales at other companies

Ionis PharmaceuticalsIONS

11.7×+5.0×

Ultragenyx PharmaceuticalRARE

3.1×-2.7×

ANI PharmaceuticalsANIP

1.9×-0.3×

AnaptysBio, Inc.ANAB

6.9×+1.8×

BridgeBio PharmaBBIO

24.8×-26.8×

Arrowhead ResearchARWR

14.1×+10.9×

Other financials

Income statement

Revenue$156.4M+7.5%

Gross profit$151.0M+7.1%

Operating income-$701.6M-3,405%

Net income-$721.8M-2,255,763%

EPS (diluted)-$2.98—

Balance sheet

Cash & equivalents$173.4M+62.2%

Total debt$411.8M+24.7%

Total equity-$553.8M-22.6%

Total assets$465.1M-3.1%

Cash flow

Operating cash flow-$61.8M-125%

CapEx$403.0K+182%

Free cash flow-$62.2M-125%

Valuation

Market cap$2.37B+52.3%

Enterprise value$2.6B+46.7%

Profitability

Gross margin97.8%+0.8pp

Operating margin-43.1%-49.7pp

Net margin-51.7%-69.7pp

FCF margin35%—

Returns & leverage

Return on equity-882.8%—

Debt / equity0.1×—

Current ratio1.9×-1.0×

Where this comes from

Calculated from BioCryst Pharmaceuticals’s reported figures.

market cap/total revenue=2.7×

Based on the most recent quarter.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is BioCryst Pharmaceuticals's price / sales?: BioCryst Pharmaceuticals (BCRX) reported price / sales of 2.7× in Q1 2026.
How has BioCryst Pharmaceuticals's price / sales changed year-over-year?: BioCryst Pharmaceuticals's price / sales decreased by 13.4% year-over-year, from 3.1× to 2.7×.
What is the long-term trend for BioCryst Pharmaceuticals's price / sales?: Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's price / sales has grown at a -52.2% compound annual growth rate (CAGR), from 75.3× to 1.9×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.